Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
- PMID: 8564842
- DOI: 10.1038/nm0196-52
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
Abstract
In this pilot study, we investigated the ability of autologous dendritic cells pulsed ex vivo with tumor-specific idiotype protein to stimulate host antitumor immunity when infused as a vaccine. Four patients with follicular B-cell lymphoma received a series of three or four infusions of antigen-pulsed dendritic cells followed, in each instance, by subcutaneous injections of soluble antigen two weeks later. All patients developed measurable antitumor cellular immune responses. In addition, clinical responses have been measured with one patient experiencing complete tumor regression, a second patient having partial tumor regression, and a third patient resolving all evidence of disease as detected by a sensitive tumor-specific molecular analysis.
Similar articles
-
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.Blood. 2009 Jan 1;113(1):18-27. doi: 10.1182/blood-2008-06-165654. Epub 2008 Sep 22. Blood. 2009. PMID: 18809757 Clinical Trial.
-
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.Cytokines Mol Ther. 1996 Dec;2(4):231-8. Cytokines Mol Ther. 1996. PMID: 9384709
-
A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.J Immunother. 2010 Feb-Mar;33(2):178-84. doi: 10.1097/CJI.0b013e3181bfcea1. J Immunother. 2010. PMID: 20145546 Clinical Trial.
-
Dendritic cells: potential role in cancer therapy.Cytotechnology. 1997;25(1-3):1-8. doi: 10.1023/a:1007997918593. Cytotechnology. 1997. PMID: 9474803 Free PMC article. Review.
-
Translational development of vaccination strategies in follicular NHL.Best Pract Res Clin Haematol. 2011 Jun;24(2):295-304. doi: 10.1016/j.beha.2011.03.007. Epub 2011 May 6. Best Pract Res Clin Haematol. 2011. PMID: 21658625 Review.
Cited by
-
The past, present and future of immunotherapy against tumor.Transl Lung Cancer Res. 2015 Jun;4(3):253-64. doi: 10.3978/j.issn.2218-6751.2015.01.06. Transl Lung Cancer Res. 2015. PMID: 26207213 Free PMC article. Review.
-
Immunotherapy using dendritic cells against multiple myeloma: how to improve?Clin Dev Immunol. 2012;2012:397648. doi: 10.1155/2012/397648. Epub 2012 Mar 15. Clin Dev Immunol. 2012. PMID: 22481968 Free PMC article. Review.
-
Breast cancer and the immune system: opportunities and pitfalls.J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):467-75. doi: 10.1023/a:1014743232598. J Mammary Gland Biol Neoplasia. 2001. PMID: 12013535 Review.
-
Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.Neoplasia. 2006 Oct;8(10):833-42. doi: 10.1593/neo.06415. Neoplasia. 2006. PMID: 17032500 Free PMC article.
-
Progress in cancer vaccines by enhanced self-presentation.Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):8933-5. doi: 10.1073/pnas.171326398. Proc Natl Acad Sci U S A. 2001. PMID: 11481463 Free PMC article. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
